Internet-delivered Cognitive Behaviour Therapy for Older Adults With Anxiety

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to determine whether tailored internet-administrated cognitive behaviour therapy (ICBT) is a feasible approach in the treatment of anxiety symptoms and comorbid depressive symptoms in older adults.

Official Title
-----------------
Individually-tailored Internet-delivered Cognitive Behaviour Therapy Treatment for Older Adults With Anxiety and Depression: a Randomized Controlled Trial

Conditions
-----------------
Anxiety, Depression

Intervention / Treatment
-----------------
* Behavioral: Waitlist
* Behavioral: Tailored Internet-delivered CBT


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Have anxiety symptoms Exclusion Criteria: Suicidal ideation Alcohol addiction Other major primary psychiatric disorder Ongoing psychological treatment

Ages Eligible for Study
-----------------
Minimum Age: 60 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Tailored Internet-delivered CBT<br>Tailored Internet-delivered CBT during 8 weeks. | Behavioral: Tailored Internet-delivered CBT<br>* Tailored Internet-delivered CBT during 8 weeks.<br>|
| Active Comparator: Waitlist<br>Weekly check-up. | Behavioral: Waitlist<br>* Weekly check up.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Beck Anxiety Inventory (BAI) | Change from baseline in symptoms two weeks post treatment and at 12 months post treatment. | Two weeks pre treatment, two weeks post treatment and 12 months post treatment | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Patient Health Questionnaire (PHQ) | Change from baseline in symptoms two weeks post treatment and at 12 months post treatment. | Two weeks pre treatment, two weeks post treatment and 12 months post treatment | 
| The Generalized Anxiety Disorder 7-item Scale (GAD-7) | Change from baseline in symptoms two weeks post treatment and at 12 months post treatment. | Two weeks pre treatment, two weeks post treatment and 12 months post treatment | 
| Quality of Life Inventory (QOLI) | Change from baseline in symptoms two weeks post treatment and at 12 months post treatment. | Two weeks pre treatment, two weeks post treatment and 12 months post treatment | 
| Montgomery Åsberg Depression Rating Scale - Self Rated (MADRS-S) | Change from baseline in symptoms two weeks post treatment and at 12 months post treatment. | Two weeks pre treatment, two weeks post treatment and 12 months post treatment | 
| Clinical Outcome in Routine Evaluation - Outcome Measure (CORE-OM) | Change from baseline in symptoms two weeks post treatment and at 12 months post treatment. | Two weeks pre treatment, two weeks post treatment and 12 months post treatment | 
| Cognitive Failures Questionnaire (CFQ) |  | Two weeks pre treatment, two weeks post treatment and 12 months post treatment | 
| Wisconsin Card Sorting Test-64 (WCST-64) |  | Two weeks pre treatment, two weeks post treatment and 12 months post treatment |